[1]
Khalid S, Kelly R, Carlton A, Wu R, Peta A, Melville P, Maasarani S, Meyer H, Adogwa O. Adult intradural intramedullary astrocytomas: a multicenter analysis. Journal of spine surgery (Hong Kong). 2019 Mar:5(1):19-30. doi: 10.21037/jss.2018.12.06. Epub
[PubMed PMID: 31032435]
[2]
Chen X, Zhang G. Multiple Spinal Intramedullary Primitive Neuroectodermal Tumors Mimicking Acute Myelitis. World neurosurgery. 2019 Jun:126():72-75. doi: 10.1016/j.wneu.2019.02.108. Epub 2019 Mar 2
[PubMed PMID: 30831283]
Level 3 (low-level) evidence
[3]
Benjamin CG, Frempong-Boadu A, Hoch M, Bruno M, Shepherd T, Pacione D. Combined Use of Diffusion Tractography and Advanced Intraoperative Imaging for Resection of Cervical Intramedullary Spinal Cord Neoplasms: A Case Series and Technical Note. Operative neurosurgery (Hagerstown, Md.). 2019 Nov 1:17(5):525-530. doi: 10.1093/ons/opz039. Epub
[PubMed PMID: 30892657]
Level 2 (mid-level) evidence
[4]
Goyal A, Yolcu Y, Kerezoudis P, Alvi MA, Krauss WE, Bydon M. Intramedullary spinal cord metastases: an institutional review of survival and outcomes. Journal of neuro-oncology. 2019 Apr:142(2):347-354. doi: 10.1007/s11060-019-03105-2. Epub 2019 Jan 17
[PubMed PMID: 30656530]
[5]
Weng Y, Zhan R, Shen J, Pan J, Jiang H, Huang K, Xu K, Huang H. Intramedullary Spinal Cord Metastasis from Renal Cell Carcinoma: A Systematic Review of the Literature. BioMed research international. 2018:2018():7485020. doi: 10.1155/2018/7485020. Epub 2018 Dec 16
[PubMed PMID: 30643818]
Level 1 (high-level) evidence
[6]
Kofod DH, Wegge C, Buhl-Jensen G. [Intramedullary spinal cord tumour as differential diagnosis to bilateral muscle weakness]. Ugeskrift for laeger. 2018 Dec 10:180(50):. pii: V04180294. Epub
[PubMed PMID: 30547876]
[7]
Chanchotisatien A, Xiong J, Yu J, Chu S. Exophytic Primary Intramedullary Spinal Cord Glioblastoma: Case Report and Critical Review of Literature. World neurosurgery. 2019 Feb:122():573-576. doi: 10.1016/j.wneu.2018.11.113. Epub 2018 Nov 23
[PubMed PMID: 30476666]
Level 3 (low-level) evidence
[8]
Eroglu U, Bozkurt M, Kahilogullari G, Dogan I, Ozgural O, Shah KJ, Zaimoglu M, Al-Beyati ESM, Ugur HC, Cohen-Gadol AA. Surgical Management of Spinal Arachnoid Cysts in Adults. World neurosurgery. 2019 Feb:122():e1146-e1152. doi: 10.1016/j.wneu.2018.11.005. Epub 2018 Nov 14
[PubMed PMID: 30447456]
[9]
Rijs K, Klimek M, Scheltens-de Boer M, Biesheuvel K, Harhangi BS. Intraoperative Neuromonitoring in Patients with Intramedullary Spinal Cord Tumor: A Systematic Review, Meta-Analysis, and Case Series. World neurosurgery. 2019 May:125():498-510.e2. doi: 10.1016/j.wneu.2019.01.007. Epub 2019 Jan 17
[PubMed PMID: 30659972]
Level 2 (mid-level) evidence
[10]
Wu J, Ranjan S. Neoplastic Myelopathies. Continuum (Minneapolis, Minn.). 2018 Apr:24(2, Spinal Cord Disorders):474-496. doi: 10.1212/CON.0000000000000585. Epub
[PubMed PMID: 29613896]
[11]
Navarro Fernández JO, Monroy Sosa A, Cacho Díaz B, Arrieta VA, Ortíz Leyva RU, Cano Valdez AM, Reyes Soto G. Cervical Intramedullary Schwannoma: Case Report and Review of the Literature. Case reports in neurology. 2018 Jan-Apr:10(1):18-24. doi: 10.1159/000467389. Epub 2018 Feb 14
[PubMed PMID: 29606952]
Level 3 (low-level) evidence
[12]
O'Neill AH, Phung TB, Lai LT. Intramedullary spinal cord metastasis from thyroid carcinoma: Case report and a systematic pooled analysis of the literature. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2018 Mar:49():7-15. doi: 10.1016/j.jocn.2017.12.001. Epub 2017 Dec 14
[PubMed PMID: 29248379]
Level 3 (low-level) evidence
[13]
Bhimani AD, Rosinski CL, Denyer S, Hobbs JG, Patel S, Shah K, Mudreac A, Diamond R, Behbahani M, Mehta AI. Acute Surgical Risk Profile of Intramedullary Spinal Cord Tumor Resection in Pediatric Patients: A Pediatric National Surgical Quality Improvement Program Analysis. World neurosurgery. 2019 Jan:121():e389-e397. doi: 10.1016/j.wneu.2018.09.113. Epub 2018 Sep 26
[PubMed PMID: 30266692]
Level 2 (mid-level) evidence
[14]
Morikawa A, de Stanchina E, Pentsova E, Kemeny MM, Li BT, Tang K, Patil S, Fleisher M, Van Poznak C, Norton L, Seidman AD. Phase I Study of Intermittent High-Dose Lapatinib Alternating with Capecitabine for HER2-Positive Breast Cancer Patients with Central Nervous System Metastases. Clinical cancer research : an official journal of the American Association for Cancer Research. 2019 Jul 1:25(13):3784-3792. doi: 10.1158/1078-0432.CCR-18-3502. Epub 2019 Apr 15
[PubMed PMID: 30988080]